Virax Biolabs Group Ltd
VRAX· Nasdaq
Virax Biolabs Group Ltd
- Last sale
- Oct 7, 2026 · +3.96%
- Market cap
- $1.22M
- 579.22K shares
- Filings
- 156
Price
Oct 7, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-03-31 | $6,331 | reported | |
| FY 2024 | 2024-03-31 | $156,419 | reported | |
| FY 2023 | 2023-03-31 | $8,561 | reported | |
| FY 2022 | 2022-03-31 | $0 | reported | |
| FY 2021 | 2021-03-31 | $123,820 | reported |
Virax Biolabs Group Ltd · CIK 1885827 · Engraved from SEC EDGAR
